Memorial Sloan Kettering Cancer Center


Klinik

Standort der Organisation:
New York, NY, Vereinigte Staaten von Amerika (USA)


Publikationen in Kooperation mit FAU-Wissenschaftlerinnen und Wissenschaftlern


Go to first page Go to previous page 2 von 4 Go to next page Go to last page
Haycock, P.C., Burgess, S., Nounu, A., Zheng, J., Okoli, G.N., Bowden, J.,... Smith, G.D. (2017). Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study. JAMA Oncology, 3(5), 636-651. https://dx.doi.org/10.1001/jamaoncol.2016.5945
Dietzel, M., Kaiser, C., Pinker, K., Wenkel, E., Hammon, M., Uder, M.,... Baltzer, P. (2017). Automated Semi-Quantitative Analysis of Breast MRI: Potential Imaging Biomarker for the Prediction of Tissue Response to Neoadjuvant Chemotherapy. Breast Care, 12(4), 231-236. https://dx.doi.org/10.1159/000480226
Kar, S.P., Adler, E., Tyrer, J., Hazelett, D., Anton-Culver, H., Bandera, E.V.,... Lawrenson, K. (2017). Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. British Journal of Cancer, 116(4), 524-535. https://dx.doi.org/10.1038/bjc.2016.426
Topper, M.J., Vaz, M., Chiappinelli, K.B., Shields, C.E.D., Niknafs, N., Yen, R.-W.C.,... Baylin, S.B. (2017). Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer. Cell, 171(6), 1284-1300.e21. https://dx.doi.org/10.1016/j.cell.2017.10.022
Weyerer, V., Schneckenpointner, R., Filbeck, T., Burger, M., Hofstaedter, F., Wild, P.J.,... Giedl, J. (2017). Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 years. Journal of Cancer, 8(3), 323-331. https://dx.doi.org/10.7150/jca.17482
Huse, J.T., Snuderl, M., Jones, D.T.W., Brathwaite, C.D., Altman, N., Lavi, E.,... Rosenblum, M.K. (2017). Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway. Acta Neuropathologica, 133(3), 417-429. https://dx.doi.org/10.1007/s00401-016-1639-9
Agaimy, A., Hartmann, A., Antonescu, C.R., Chiosea, S.I., El-Mofty, S.K., Geddert, H.,... Bishop, J.A. (2017). SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity. American Journal of Surgical Pathology, 41(4), 458-471. https://dx.doi.org/10.1097/PAS.0000000000000797
Dixon, S.C., Nagle, C.M., Thrift, A.P., Pharoah, P.D.P., Pearce, C.L., Zheng, W.,... Webb, P.M. (2016). Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. International Journal of Epidemiology, 45(3), 884-95. https://dx.doi.org/10.1093/ije/dyw158
Schmidt, M.K., Hogervorst, F., Van Hien, R., Cornelissen, S., Broeks, A., Adank, M.A.,... Easton, D.F. (2016). Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. Journal of Clinical Oncology, 34(23), 2750-60. https://dx.doi.org/10.1200/JCO.2016.66.5844
Cuellar-Partida, G., Lu, Y., Dixon, S.C., Fasching, P.A., Hein, A., Burghaus, S.,... Macgregor, S. (2016). Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. Human genetics, 135(7), 741-56. https://dx.doi.org/10.1007/s00439-016-1663-9
Hampras, S.S., Sucheston-Campbell, L.E., Cannioto, R., Chang-Claude, J., Modugno, F., Doerk, T.,... Moysich, K.B. (2016). Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget. https://dx.doi.org/10.18632/oncotarget.10215
Ong, J.-S., Cuellar-Partida, G., Lu, Y., Fasching, P.A., Hein, A., Burghaus, S.,... Macgregor, S. (2016). Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. International Journal of Epidemiology, 45(5), 1619-1630. https://dx.doi.org/10.1093/ije/dyw207
Weide, B., Martens, A., Hassel, J.C., Berking, C., Postow, M.A., Bisschop, K.,... Wolchok, J.D. (2016). Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab. Clinical Cancer Research, 22(22), 5487-5496. https://dx.doi.org/10.1158/1078-0432.CCR-16-0127
Bailey, P., Chang, D.K., Nones, K., Johns, A.L., Patch, A.-M., Gingras, M.-C.,... Pilarsky, C. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52. https://dx.doi.org/10.1038/nature16965
Stamatiades, E.G., Tremblay, M.-E., Bohm, M., Crozet, L., Bisht, K., Kao, D.,... Geissmann, F. (2016). Immune Monitoring of Trans-endothelial Transport by Kidney-Resident Macrophages. Cell, 166(4), 991-1003. https://dx.doi.org/10.1016/j.cell.2016.06.058
Permuth, J.B., Reid, B., Earp, M., Chen, Y.A., Monteiro, A.N.A., Chen, Z.,... Sellers, T.A. (2016). Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration. Oncotarget, 7(45), 72381-72394. https://dx.doi.org/10.18632/oncotarget.10546
Van Den Wyngaert, T., Strobel, K., Kampen, W.U., Kuwert, T., Van Der Bruggen, W., Mohan, H.K.,... Paycha, F. (2016). The EANM practice guidelines for bone scintigraphy. European Journal of Nuclear Medicine and Molecular Imaging, 43(9), 1723-38. https://dx.doi.org/10.1007/s00259-016-3415-4
Kovar, H., Amatruda, J., Brunet, E., Burdach, S., Cidre-Aranaz, F., De Alava, E.,... Delattre, O. (2016). The second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex disease. Oncotarget, 7(8), 8613-24. https://dx.doi.org/10.18632/oncotarget.6937
Smith, S.C., Trpkov, K., Chen, Y.-B., Mehra, R., Sirohi, D., Ohe, C.,... Amin, M.B. (2016). Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma. American Journal of Surgical Pathology, 40(11), 1457-1472. https://dx.doi.org/10.1097/PAS.0000000000000719
Lawrenson, K., Li, Q., Kar, S., Seo, J.-H., Tyrer, J., Spindler, T.J.,... Defazio, A. (2015). Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nature Communications, 6, 8234. https://dx.doi.org/10.1038/ncomms9234

Zuletzt aktualisiert 2016-29-04 um 08:06